铜绿假单胞菌寡核苷酸酶的纯化、结晶和活性验证

doi:10.13481/j.1671-587X.20220504

摘要/Abstract

摘要：

目的研究致病菌铜绿假单胞菌寡核苷酸酶（PaOrn）的三维结构和体外水解活性，验证PaOrn活性位点并探讨PaOrn对铜绿假单胞菌（P.aeruginosa）胞内3'，5'-环二鸟苷（c-di-GMP）水平和致病毒性的影响。方法构建重组质粒pET 32M3C-PaOrn，在大肠杆菌（E.coli）BL21中诱导表达目的蛋白，获得组氨酸（His）标签和谷胱甘肽（GST）标签标记。采用多级纯化方法纯化蛋白，经Ni亲和层析、GST亲和层析和阴离子交换层析后获得高纯度和高均一性PaOrn目的蛋白。采用商业化结晶试剂和坐滴法筛选晶体，根据晶体状态进一步优化。采用X射线衍射法验证晶体质量，分辨率高于3 ?时用于结构解析。采用高分辨质谱技术Q TOF验证PaOrn蛋白水解底物二鸟苷磷酸（pGpG）活性，鸟苷单磷酸（GMP）产物作为验证活性的指标。采用尿素聚丙烯酰胺（Urea-PAGE）法验证PaOrn蛋白和点突变PaOrn蛋白（Orn^D11A、Orn^E13A、Orn^D111A、Orn^H157A和Orn^D162A）对10 nt长度寡核苷酸RNA的水解活性，降解条带作为活性正常的分析指标。结果经原核系统表达和多级纯化，得到纯度高达95%的目的蛋白PaOrn。于结晶试剂Wizard Ⅰ#12［1.0 mmol·L^－1（NH₄）₂HPO₄，0.1 mmol·L^－1 Imidazole］ pH 8.0条件下生长出质量较好的单晶，晶体PaOrn的分辨率为1.85 ?，复合物PaOrn-GMP和PaOrn^D11A-pGpG的分辨率分别为1.90 ?和1.70 ?。高分辨质谱，PaOrn将底物pGpG水解为GMP。尿素聚丙烯酰胺凝胶电泳，PaOrn可降解长达10 nt的RNA，当活性位点Asp11、Glu13、Asp111、His157和Asp162分别突变后，PaOrn丧失活性，无法降解底物pGpG和RNA（10 nt）。结论 PaOrn通过降解寡核苷酸参与调控胞内c-di-GMP和RNA水平，影响转录起始和细胞多种生物学行为。

关键词: 铜绿假单胞菌, 寡核苷酸酶, 3',5'-环二鸟苷, 蛋白纯化, 晶体筛选

Abstract:

Objective To investigate the three-dimensional structure of oligoribonuclease from Pseudomonas aeruginosa （P.aeruginosa） Orn （PaOrn），and to verify the active sites of PaOrn，and explore the effect of PaOrn on the intracellular Bis-（3'-5'） cyclic diguanylic acid（c-di-GMP） levels and virulence of P. aeruginosa. Methods A fusion protein with a histidine （His） tag and a glutathione （GST） tag was obtained by constructing the recombinant plasmid pET 32M3C-PaOrn that was expressed by the Escherichia coli（E. coli） BL21.The protein was purified with multistage purifiation method； after Ni affinity chromatography， GST affinity chromatography， and anion exchange chromatography， and finally yielding the PaOrn target protein with high purity and high homogeneity were obtained.The crystals were screened with commercial crystallization reagents and sitting drops， and they were further optimized according to the crystal state. The quality of crystal was verified by X-ray diffraction method， and resolution above 3 ? was used for structure resolution.The activity of PaOrn degradation 5'-phosphoguanylyl-（3'，5'）-guanosine（pGpG） was verified by using high resolution mass spectrometry Q TOF， and the GMP product was used as an indicator to verify the activity. The hydrolytic activities of the PaOrn and the mutant PaOrn proteins （Orn^D11A， Orn^E13A， Orn^D111A， Orn^H157A， and Orn^D162A） against the 10 nt RNA was verified by using Urea-PAGE， and the degradation bands were used as analytical indicators for the normal activity. Results The target protein PaOrn was obtained with purity up to 95% after prokaryotic expression and multistage purification. Good quality single crystals were grown at Wizard Ⅰ # 12［1.0 mmol·L^－1（NH₄）₂HPO₄， 0.1 mmol·L^－1 Imidazole］ pH 8.0， the resolution of crystal PaOrn was 1.85 ?，and the resolutions of PaOrn-GMP complex and PaOrn^D11A-pGpG complex were 1.90 ? and 1.70 ?， respectively.The Urea-PAGE results showed that PaOrn hydrolyzed the substrate pGpG to GMP. The urea polyacrylamide gel electrophoresis results revealed that PaOrn could degrade up to 10 nt of RNA， and after mutation of the active sites of PaOrn （Asp11， Glu13， Asp111， His157， and Asp162），the activity of PaOrn was lost，and failed to degrade the substrate pGpG and RNA（10 nt）. Conclusion PaOrn is involved in the regulation of intracellular c-di-GMP and RNA levels through degradation of oligonucleotides，and affects transcription initiation and the multiple cellular biological behaviors.

Key words: Pseudomonas aeruginosa, Oligoribonuclease, c-di-GMP, Protein purification, Crystal screening

中图分类号:

R378.991

张建羽,张琼林. 铜绿假单胞菌寡核苷酸酶的纯化、结晶和活性验证[J]. 吉林大学学报(医学版), 2022, 48(5): 1124-1130.

Jianyu ZHANG,Qionglin ZHANG. Purification, crystallization and activity validation of oligoribonuclease from Pseudomonas aeruginosa[J]. Journal of Jilin University(Medicine Edition), 2022, 48(5): 1124-1130.

图/表 9

图1

图2

图3

图4

图5

图6

图7

图8

图9

参考文献 21

1	BERUBE B J， RANGEL S M， HAUSER A R. Pseudomonas aeruginosa： breaking down barriers［J］. Curr Genet， 2016， 62（1）： 109-113.
2	KERR K G， SNELLING A M. Pseudomonas aeruginosa： a formidable and ever-present adversary［J］. J Hosp Infect， 2009， 73（4）： 338-344.
3	KIELHOFNER M， ATMAR R L， HAMILL R J，et al. Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection［J］. Clin Infect Dis， 1992， 14（2）： 403-411.
4	SILBY M W， WINSTANLEY C， GODFREY S A C， et al. Pseudomonas genomes： diverse and adaptable［J］. FEMS Microbiol Rev， 2011， 35（4）： 652-680.
5	TACCONELLI E， CARRARA E， SAVOLDI A，et al. Discovery，research， and development of new antibiotics： the WHO priority list of antibiotic-resistant bacteria and tuberculosis［J］.Lancet Infect Dis，2018，18（3）：318-327.
6	RÖMLING U， GALPERIN M Y， GOMELSKY M. Cyclic di-GMP：the first 25 years of a universal bacterial second messenger［J］.Microbiol Mol Biol Rev，2013， 77（1）：1-52.
7	ZHANG H N， XU Z W， JIANG H W， et al. Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide［J］. Sci Rep， 2017， 7（1）： 5860.
8	ORR M W， DONALDSON G P， SEVERIN G B，et al. Oligoribonuclease is the primary degradative enzyme for pGpG in Pseudomonas aeruginosa that is required for cyclic-di-GMP turnover［J］. Proc Natl Acad Sci U S A， 2015， 112（36）： E5048-E5057.
9	COHEN D， MECHOLD U， NEVENZAL H， et al. Oligoribonuclease is a central feature of cyclic diguanylate signaling in Pseudomonas aeruginosa［J］. Proc Natl Acad Sci U S A， 2015，112（36）：11359-11364.
10	MOSCOSO J A， MIKKELSEN H， HEEB S， et al. The Pseudomonas aeruginosa sensor RetS switches type Ⅲ and type Ⅵ secretion via c-di-GMP signalling［J］. Environ Microbiol， 2011， 13（12）： 3128-3138.
11	TISCHLER A D， CAMILLI A. Cyclic diguanylate regulates Vibrio cholerae virulence gene expression［J］. Infect Immun， 2005， 73（9）： 5873-5882.
12	MAKOWSKI L， BARDHAN J， GORE D， et al. Multi-wavelength anomalous diffraction using medium-angle X-ray solution scattering （MADMAX）［J］. Biophys J， 2012， 102（4）： 927-933.
13	Summer H， Grämer R， Dröge P. Denaturing urea polyacrylamide gel electrophoresis （urea PAGE）［J］. J Vis Exp， 2009，32： 1485.
14	CRISAFULI F A P， RAMOS E B， ROCHA M S. Characterizing the interaction between DNA and GelRed fluorescent stain［J］. Eur Biophys J， 2015， 44（1/2）： 1-7.
15	XIE C， ZHONG D F， YU K T， et al. Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-TOF MS［J］. Bioanalysis，2012，4（8）：937-959.
16	KIM S K， LORMAND J D， WEISS C A， et al. A dedicated diribonucleotidase resolves a key bottleneck for the terminal step of RNA degradation［J］. eLife， 2019， 8： e46313.
17	LIAO H B， LIU M F， GUO X L. The special existences： nanoRNA and nanoRNase［J］. Microbiol Res， 2018， 207： 134-139.
18	SUTTON J M， ZAHAR N MEL， BARTLETT M G. Oligonucleotide anion adduct formation using negative ion electrospray ion-mobility mass spectrometry ［J］. J Am Soc Mass Spectrom， 2021， 32（2）： 497-508.
19	ORR M W， WEISS C A， SEVERIN G B， et al. A subset of exoribonucleases serve as degradative enzymes for pGpG in c-di-GMP signaling［J］. J Bacteriol， 2018， 200（24）： e00300-e00318.
20	CHU L， AGRAWAL S， CHEN Y P， et al. Structural insights into nanoRNA degradation by human Rexo2［J］. RNA， 2019， 25（6）： 737-746.
21	MCCARTHY R R， VALENTINI M， FILLOUX A. Contribution of cyclic di-GMP in the control of type Ⅲ and type Ⅵ secretion in Pseudomonas aeruginosa ［J］. Methods Mol Biol， 2017， 1657： 213-224.

[1]	李时孟, 赵丽纯, 乔璐, 何成彦, 刘卓. ATP5B原核表达和单克隆抗体的制备及其鉴定[J]. 吉林大学学报(医学版), 2019, 45(01): 184-189.
[2]	李会敏, 伊焕发. 刚地弓形虫肌动蛋白profilin的原核表达和纯化[J]. 吉林大学学报(医学版), 2017, 43(06): 1109-1114.
[3]	陈盛\|余加林\|罗则佳\|何念海\|孙凤军. 巯乙磺酸钠联合环丙沙星对铜绿假单胞菌生物膜的作用[J]. J4, 2012, 38(4): 623-627.
[4]	杨南扬, 缪璇, 伍贤军, 刘金美, 辻一郎, 李晓萌. 类泛素化修饰蛋白SUMO3 /GST融合蛋白表达载体的构建及表达[J]. J4, 2011, 37(6): 1010-1014.
[5]	陈光\|吴铭\|王刚\|孙旸. 重组人胶原蛋白肽在大肠杆菌中的高效表达[J]. J4, 2011, 37(4): 656-660.
[6]	刘晓彬, 王珂, 成伏波, 孙延波, 徐德启. 噬菌体对小鼠肠源性铜绿假单胞菌感染的治疗作用[J]. J4, 2009, 35(4): 660-663.